Talk:Tomáš Cihlář
Latest comment: 4 years ago by Yoninah in topic Did you know nomination
| This article must adhere to the biographies of living persons (BLP) policy, even if it is not a biography, because it contains material about living persons. Contentious material about living persons that is unsourced or poorly sourced must be removed immediately from the article and its talk page, especially if potentially libellous. If such material is repeatedly inserted, or if you have other concerns, please report the issue to this noticeboard.If you are a subject of this article, or acting on behalf of one, and you need help, please see this help page. |
 | This article is rated C-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
.svg){kind=small}
 | Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Tomáš Cihlář.
|
Did you know nomination
edit- The following is an archived discussion of the DYK nomination of the article below. Please do not modify this page. Subsequent comments should be made on the appropriate discussion page (such as this nomination's talk page, the article's talk page or Wikipedia talk:Did you know), unless there is consensus to re-open the discussion at this page. No further edits should be made to this page.
The result was: rejected by Yoninah (talk) 11:15, 21 June 2020 (UTC)
Issues raised in review unaddressed
( )
- ... that as a student, Czech American virologist Tomáš Cihlář, known today for developing hopeful anti-Covid-19 drug remdesivir, assisted Antonín Holý in developing tenofovir disoproxil, the primary drug used in the fight against HIV?[1][2]
- ALT1:... that Czech American virologist Tomáš Cihlář is credited with developing both tenofovir disoproxil to fight HIV and remdesivir to fight Covid-19?[1][2]
- Reviewed: Template:Did you know nominations
- Created/expanded by Swmmng (talk). Self-nominated at 13:12, 23 April 2020 (UTC).
@Swmmng: New and long enough, Earwig detects no copyvios. I'd like to see more specifics and better sourcing about Cihlář's involvement in developing remdesivir; these are generally large team efforts and simply saying he developed it himself isn't sufficient detail. Was he a laboratory scientist, a research group head, or was it in his executive position at Gilead? John P. Sadowski (NIOSH) (talk) 23:39, 21 May 2020 (UTC)
Nominator has not edited since June 9. But I am leaving a note on his talk page giving him a week to respond to this review or else the nomination will be closed as unsuccessful. Yoninah (talk) 20:06, 15 June 2020 (UTC)
The nominator hasn't edited since the 9th and has not responded to the comments left in the nomination or addressed the above issues; their last edit to the article (and their most recent edit on Wikipedia) did not give the necessary specifics requested above. Marking for closure as unsuccessful. Narutolovehinata5 tccsdnew 02:49, 21 June 2020 (UTC)
References
- ^ a b Anon., "Remdesivir Cleared For Use On Covid-19 Patients in Four Czech Hospitals", Prague Morning, April 29, 2020.
- ^ a b Saiver, F., "Je Remdesivir lékem na covid-19? O objevu týmu Tomáše Cihláře má být jasno už do konce dubna", Forbes, April 8, 2020.